ATIGEN

Basic Information

ATIGEN
111 RESEARCH DR
BETHLEHEM, PA, 18015

Company Profile

n/a

Additional Details

Field Value
DUNS: 612251467
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. A novel approach for gene therapy

    Amount: $139,916.00

    DESCRIPTION (provided by applicant): Many human diseases have been traced back to single genetic mutations in the genome that are causative for the disorder, such as Lesch-Nyhan Syndrome, Cystic Fibro ...

    STTR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government